Home ›
Data Desk › State Street Corp passes 5.0% of Recursion Pharmaceuticals Inc.
MarginsX Data Desk · 13G holders · Artificial intelligence · Carbon and clean energy credits · Oncology
State Street Corp passes 5.0% of Recursion Pharmaceuticals Inc. In a Schedule 13G filed Nov 10, 2026, State Street Corp reported 30.0 million shares of Recursion Pharmaceuticals Inc. (RXRX) as of Sep 30, 2026, 5.6% of the class. (SEC EDGAR, SCHEDULE 13G, Nov 10, 2026)
By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 10, 2026.
The threshold
A passive holder files this schedule once it owns more than 5.0% of a class. (SEC EDGAR, SCHEDULE 13G, Nov 10, 2026 )
The stock
The Nasdaq screener puts its market value at $2.0B. (Nasdaq stock screener, Nov 13, 2026 )
Follow it up
The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/RXRX )
The filing on SEC EDGAR. (sec.gov )
The filing in the MarginsX reader. (MarginsX reader )
Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.
Facts behind this article Fact Value Source As of Filer State Street Corp Source 2026-11-10 Level 5 % Source 2026-11-10 Name Recursion Pharmaceuticals Inc. Source 2026-11-13 Form Schedule 13G Source 2026-11-10 Filed Nov 10, 2026 Source 2026-11-10 Shares 30,001,137 shares Source 2026-11-10 Who Recursion Pharmaceuticals Inc. (RXRX) Source 2026-11-13 Symbol RXRX Source 2026-11-13 Event date Sep 30, 2026 Source 2026-11-10 Pct 5.6 % Source 2026-11-10 Cap 1,983,488,239 USD Source 2026-11-13
Sources
Automated from SEC filings and market data. No AI. For information only. Not investment advice.
Discuss in MarginsX More from the Data Desk
More on MarginsX Companies in this article Topics Related Data Desk stories Every Data Desk article: /desk · RSS